Patents by Inventor Claudio Avila

Claudio Avila has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20170224765
    Abstract: The invention concerns the use of cyclophilin inhibitors in the treatment of Hepatitis C virus infection.
    Type: Application
    Filed: April 26, 2017
    Publication date: August 10, 2017
    Inventor: Claudio Avila
  • Publication number: 20160258904
    Abstract: A method for controlling a process stream comprises detecting interfaces that are present in the process stream under a set of conditions using a phased array ultrasound probe, reconstructing an image of the interfaces, and providing the image, or information derived therefrom, to a control system. The control system either modifies or maintains the set of conditions in process stream. The method may be used for controlling an industrial process stream, such as a process stream in a chemical or petrochemical processing plant.
    Type: Application
    Filed: February 15, 2016
    Publication date: September 8, 2016
    Applicant: BP Corporation North America Inc.
    Inventors: Margarit Lozev, Edo Becker, Steven Orwig, Claudio Avila, Gordana Djordjevic, Anthony Gachagan, Craig Herdsman, Anthony Mulholland, Andrew Poole, George Vickers
  • Publication number: 20160235808
    Abstract: The invention concerns the use of cyclophilin inhibitors in the treatment of Hepatitis C virus infection.
    Type: Application
    Filed: April 28, 2016
    Publication date: August 18, 2016
    Inventors: Claudio Avila, Rafael Crabbe
  • Publication number: 20150328280
    Abstract: The invention concerns the use of cyclophilin inhibitors in the treatment of Hepatitis C virus infection.
    Type: Application
    Filed: July 27, 2015
    Publication date: November 19, 2015
    Inventor: Claudio Avila
  • Publication number: 20150273015
    Abstract: The invention concerns the use of cyclophilin inhibitors in the treatment of Hepatitis C virus infection.
    Type: Application
    Filed: June 10, 2015
    Publication date: October 1, 2015
    Applicant: Novartis AG
    Inventor: Claudio Avila
  • Publication number: 20150258167
    Abstract: The invention concerns the use of cyclophilin inhibitors in the treatment of Hepatitis C virus genotype 2 or 3 infection.
    Type: Application
    Filed: May 28, 2015
    Publication date: September 17, 2015
    Inventors: Claudio Avila, Rafael Crabbé, Nikolai Naoumov
  • Publication number: 20150139950
    Abstract: The disclosure concerns the use of cyclophilin inhibitors in the treatment of chronic Hepatitis C virus infection.
    Type: Application
    Filed: November 13, 2014
    Publication date: May 21, 2015
    Applicant: Novartis AG
    Inventor: Claudio Avila
  • Publication number: 20150104415
    Abstract: The invention concerns the use of cyclophilin inhibitors in the treatment of Hepatitis C virus infection.
    Type: Application
    Filed: April 11, 2012
    Publication date: April 16, 2015
    Applicants: DEBIOPHARM INTERNATIONAL SA, NOVARTIS AG
    Inventors: Claudio Avila, Rafael Crabbe
  • Publication number: 20140228281
    Abstract: The invention concerns the use of cyclophilin inhibitors in the treatment of Hepatitis C virus infection.
    Type: Application
    Filed: September 25, 2012
    Publication date: August 14, 2014
    Inventor: Claudio Avila
  • Publication number: 20140018289
    Abstract: The disclosure concerns the use of cyclophilin inhibitors in the treatment of chronic Hepatitis C virus infection.
    Type: Application
    Filed: March 29, 2012
    Publication date: January 16, 2014
    Applicant: NOVARTIS AG
    Inventor: Claudio Avila
  • Publication number: 20130251678
    Abstract: The invention concerns the use of cyclophilin inhibitors in the treatment of Hepatitis C virus infection.
    Type: Application
    Filed: November 29, 2011
    Publication date: September 26, 2013
    Applicant: NOVARTIS AG
    Inventor: Claudio Avila
  • Publication number: 20130225483
    Abstract: The invention concerns the use of cyclophilin inhibitors in the treatment of Hepatitis C virus genotype 2 or 3 infection.
    Type: Application
    Filed: October 3, 2011
    Publication date: August 29, 2013
    Inventors: Claudio Avila, Rafael Crabbé, Nikolai Naoumov